Scientist, Biology at Gilead Sciences

Foster City, California, United States

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, PharmaceuticalsIndustries

Requirements

Bachelor’s in a relevant scientific discipline with at least 6 years of industry experience in in vivo pharmacology, or Master’s degree in a relevant scientific discipline with at least 4 years of industry experience in in vivo pharmacology
Hands-on experience with mouse models of inflammatory diseases (e.g., experimental colitis, fibrosis)
Proficiency in mouse handling techniques including IV, PO, SC, and IP dosing, necropsy, and tissue collection
Experience with lymphocyte FACS sorting, magnetic bead-based cell isolation, and multi-color flow cytometry (10+ colors)
Strong organizational and communication skills
Ability to work independently and contribute effectively in a multidisciplinary team environment
Preferred Qualifications
Ph.D. or equivalent degree with 0–3 years of research experience in industry or academic settings
Deep understanding of biological pathways involved in inflammatory disease pathogenesis
Prior experience in developing and characterizing mouse models for preclinical research
Demonstrated ability to communicate complex scientific concepts clearly across teams
Experience in ex vivo analysis and data interpretation related to immune cell profiling

Responsibilities

Design, conduct, analyze, and report in vivo studies to support preclinical research objectives
Develop, optimize, and characterize preclinical models, particularly for inflammatory and fibrotic diseases (e.g., colitis, MASH)
Interface with cross-functional project teams and present findings at departmental and team meetings
Collaborate with internal stakeholders to ensure alignment on study design and execution
Design, generate, and communicate pharmacology data of preclinical models internally to support inflammatory target discovery for autoimmunity and fibrotic diseases

Skills

Preclinical Models

Autoimmune Diseases

Colitis

Fibrosis

MASH

Pharmacology

Inflammatory Therapeutics

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters

1987Year Founded

$15,873.6MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Paid family time off and paid parental time off

Generous 401(k) contribution matching

Comprehensive medical plans that cover both physical and mental healthcare

Global Wellbeing Reimbursement

Time Off

Global Volunteer Day

Giving Together Program

Employee Support Programs

Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.

Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.

Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.

Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.

Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.

Investment in digital health technologies enhances Gilead's R&D and patient engagement.

Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI

Try Jobo Free